Liver Disease

All articles by Liver Disease

Sagimet’s liver drug impresses in year-long NASH trial
Sagimet’s liver drug impresses in year-long NASH trial
Marc Iskowitz
January 23, 2024
9:45 am

The pill from Sagimet Biosciences led to a statistically significant treatment effect in patients with NASH and moderate-to-severe liver fibrosis at the 52-week mark, data show.

Connecting the dots: Salix’s campaign educates patients on link between liver disease, OHE
Connecting the dots: Salix’s campaign educates patients on link between liver disease, OHE
John Newton
May 1, 2023
11:31 am

Salix’s I Wish I Knew effort supports patients, caregivers and HCPs on addressing overt hepatic encephalopathy.

GENFIT to acquire Versantis, expanding its liver disease portfolio
GENFIT to acquire Versantis, expanding its liver disease portfolio
Jack O'Brien
September 19, 2022
3:24 pm

The late-stage biopharmaceutical company expects the deal to close in Q4 2022.

  • From Our Partners